GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $79,000 | -36.8% | 16,427 | -20.4% | 0.00% | -33.3% |
Q3 2019 | $125,000 | -72.8% | 20,627 | -68.2% | 0.01% | -78.6% |
Q1 2019 | $460,000 | +22.7% | 64,911 | +27.0% | 0.03% | +64.7% |
Q3 2018 | $375,000 | -11.3% | 51,113 | -22.9% | 0.02% | 0.0% |
Q2 2018 | $423,000 | -40.3% | 66,313 | -49.1% | 0.02% | -39.3% |
Q1 2018 | $708,000 | +238.8% | 130,214 | +159.4% | 0.03% | +211.1% |
Q4 2017 | $209,000 | -48.5% | 50,190 | +58.3% | 0.01% | -52.6% |
Q1 2017 | $406,000 | -41.6% | 31,700 | -44.2% | 0.02% | -53.7% |
Q4 2016 | $695,000 | +281.9% | 56,800 | +266.5% | 0.04% | -30.5% |
Q3 2016 | $182,000 | -42.0% | 15,500 | -74.1% | 0.06% | +321.4% |
Q1 2016 | $314,000 | -51.9% | 59,748 | -29.1% | 0.01% | -54.8% |
Q4 2015 | $653,000 | +26.1% | 84,248 | +111.0% | 0.03% | +72.2% |
Q1 2015 | $518,000 | +165.6% | 39,923 | +83.1% | 0.02% | +100.0% |
Q3 2014 | $195,000 | -44.4% | 21,799 | -38.3% | 0.01% | -52.6% |
Q1 2014 | $351,000 | -40.1% | 35,350 | -37.7% | 0.02% | 0.0% |
Q2 2013 | $586,000 | – | 56,705 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |